1. Clinical & Scientific Overview
Trihexyphenidyl (Benzhexol) Hydrochloride (TIP-MED-000455, Reference Code [11.23]) is classified under
Neurology Medicines as a Centrally Acting Antimuscarinic (M1) Anticholinergic for Drug-Induced Extrapyramidal Symptoms (Schedule H | NLEM 2022).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC Pharmacist-Assisted Counselling.
Representative Indian Formulations (for identification only): Pacitane (Pfizer), Parkin (Micro Labs), Bexol (Intas), Tryphen | Strengths: Tablets: 2 mg (often co-prescribed or formulated in psychiatric FDCs with Risperidone or Haloperidol — e.g., Sizodon Plus, Risdone Plus)
Standard hospital formulary strengths
3. Mechanism of Action & Pharmacodynamics
Established pharmacological class action (Centrally Acting Antimuscarinic (M1) Anticholinergic for Drug-Induced Extrapyramidal Symptoms (Schedule H | NLEM 2022)): targets primary receptor, enzyme, ion-channel, or cellular pathway to achieve therapeutic efficacy in Treatment of acute and chronic Drug-Induced Extrapyramidal Symptoms (EPS: acute dystonia, parkinsonian rigidity, resting tremor — NOT tardive dyskinesia or akathisia!) caused by D2-blocking antipsychotics (Haloperidol, Risperidone).
4. Therapeutic Indications & Evidence-Supported Uses
- Treatment of acute and chronic Drug-Induced Extrapyramidal Symptoms (EPS: acute dystonia, parkinsonian rigidity, resting tremor — NOT tardive dyskinesia or akathisia!) caused by D2-blocking antipsychotics (Haloperidol, Risperidone)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Start 1 mg PO OD, titrate gradually to 2 mg PO BD–TDS (Typical maintenance 2–6 mg/day; Max 10–15 mg/day in severe dystonia) (Duration: Re-evaluate need every 3 months in antipsychotic-treated patients (many patients do NOT need lifelong prophylactic Pacitane once antipsychotic dose is stabilised!);)
Administration & Meal Timing: Oral (PO), Parenteral (IV / IM / SC as specified) | Food & Meal Timing: Take WITH or immediately after meals (reduces GI upset and dry mouth) | Best Time of Day: Morning & Afternoon/Evening with meals (Avoid late night dose if it causes restlessness/delirium)
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Hospital pharmacokinetic profile; monitor therapeutic response and organ clearance.
Renal & Hepatic: Use lowest dose with caution
Renal & Hepatic: Use lowest dose with caution
Renal & Hepatic: Use lowest dose with caution
7. Contraindications, Precautions & High-Risk Warnings
- CONTRAINDICATED in narrow-angle glaucoma, Tardive Dyskinesia (Trihexyphenidyl WORSENS choreoathetoid tongue/lip movements of tardive dyskinesia!), dementia / Alzheimer's disease (directly antagonises Donepezil/Rivastigmine and causes acute delirium!), obstructive BPH urinary retention, paralytic ileus, myasthenia gravis, and megacolon
Key Clinical Precautions: High-alert hospital specialist agent; administer under close physiological and laboratory monitoring.
8. Adverse Effects Profile
- Dry mouth (xerostomia), blurred near vision (cycloplegia/mydriasis), constipation, urinary hesitancy/retention, sinus tachycardia, decreased sweating (anhidrosis), confusion/memory impairment, euphoria (potential for recreational anticholinergic abuse!)
- Monitor for hemodynamic instability, organ toxicity, or severe hypersensitivity.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- DIRECT PHARMACODYNAMIC CLASH WITH DONEPEZIL / RIVASTIGMINE / GALANTAMINE: Trihexyphenidyl blocks central M1 muscarinic receptors while Cholinesterase Inhibitors increase acetylcholine — co-prescribing both cancels out both drugs and precipitates cognitive decline! Additive severe Anticholinergic Bur
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Continuous clinical, hemodynamic, and organ-function laboratory monitoring.
Pharmacist Patient Counselling Points:
- THREE VITAL COUNTER RULES: (1) Take Pacitane/Parkin after meals and stay cool and well-hydrated in summer (it reduces sweating and can cause heat stroke)
- (2) Never give to an elderly patient with memory loss/dementia or someone taking Donepezil
Storage, Stability & Dispensing Safeguards: Store in original moisture-protected packaging below 25°C–30°C (or 2°C–8°C cold chain if parenteral/biological vial specified in strengths: Tablets: 2 mg (often co-prescribed or formulated in psychiatric FDCs with Risperidone or Haloperidol — e.g., Sizodon Plus, Risdone Plus)). Missed-Dose Rule: Take with next meal if remembered; never stop abruptly (rebound cholinergic cholinergic rebound & parkinsonian stiffness)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO • NCBI Bookshelf
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [3.1] Amlodipine (as Amlodipine Besylate) — Dihydropyridine Calcium Channel Blocker (CCB); Arterial Vasodilat
- [11.16] Nortriptyline & Clomipramine Hydrochloride — Secondary & Tertiary Amine Tricyclic Antidepressants — TCAs (Sche
- [11.18] Etizolam, Chlordiazepoxide & Clobazam — Thienodiazepine, Long-Acting 1,4-Benzodiazepine & 1,5-Benzodiazep
- [11.28] Sumatriptan, Rizatriptan & Betahistine / Cinnarizine / Flunarizine — 5-HT1B/1D Receptor Agonist Acute Migraine Triptans & Vestibular/M